estern bioethical tradition focuses on the importance of individual autonomy and choice over healthcare decisions. Indeed, healthcare practitioners expend considerable energy instructing, coaxing, and cajoling patients to take control of their own health. Messages to control weight, blood pressure, medication regimens, diabetes, and other conditions permeate society, ranging from individualized patient teaching episodes to mass media marketing strategies. Yet some practitioners voice surprise and dismay when people with life-limiting illness express a desire to control the timing and circumstances of the end-of-life experience.
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As introduced in part I of this article (see pp. 945-953), the concept of control over end-of-life care has not been well explored. Steinhauser et al. (2000) studied factors considered important at the end of life by surveying 340 seriously ill patients under the care of the Veterans Administration system. The authors used a 44-item survey tool designed to capture attributes of experience at the end of life. Although none of the attributes explicitly included the word "control," items addressed issues such as freedom from distressing symptoms, being kept clean, and naming a decision maker. Because the study used a survey tool with forced-choice attributes, respondents did not have the opportunity to register other concerns that may have related to control over the dying process. Teno, Casey, Welch, and Edgman-Levitan (2001) sought to develop domains of care that define quality end-of-life care by reviewing published professional care guidelines and conducting focus groups with family members who recently had lost loved ones. Of the five domains identified by focus group members, one included the idea of control and was described as helping dying people to control decisions about treatment and daily routines. Although bereaved family members represent an important voice, validation studies of these care domains with patients are warranted.
Studies of older patients' preferences for end-of-life care also are emerging. Vig, Davenport, and Pearlman (2002) Research Approach: Descriptive, naturalistic, using Denzin's model of interpretive interactionism.
Setting: A variety of urban and rural communities throughout the state of Texas.
Participants: 7 people with advanced cancer diagnoses. Methodologic Approach: Participants were recruited via oncology advanced practice nurses who also participated in the study. Interviews were recorded on audiotape and analyzed via Denzin's interpretive process of data analysis.
Main Research Variables: Patient control.
Findings: Thematic analysis revealed six themes: protection of dignity, control of pain and other symptoms associated with disease, management of treatment, management of how remaining time is spent, management of impact on family, and control over the dying process.
Conclusions: Participants expressed a wide variety of preferences for personal control and comfort. Their desires reflected personal values and beliefs about how they spend their time and how they want control over their care.
Interpretation: Nurses must be sensitive to the variety of preferences their patients with advanced cancer may have for engagement in decisions regarding treatment, care management, and activities of daily life. This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints or request permission to reproduce multiple copies, please e-mail reprints@ons.org. 
